Spero Therapeutics : Enters Into a Non-Dilutive Revenue Interest Financing Agreement With HealthCare Royalty Partners® for Up to $125 Million marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
HealthCare Royalty Management: HCR Expands Team and Announces Promotions
Expansion of West Coast Presence:
HCR has appointed Matthew H. Bullard as a Managing Director based in San Francisco, CA. We are very pleased to welcome Matt to the HCR team, said Clarke B. Futch, Chief Executive Officer and Chairman at HCR. With over two decades of healthcare experience, Matt brings a wealth of knowledge and relationships to HCR. Matt will round out HCR s team on the West Coast, which has been one of our most important markets. Matt s addition along with HCR s existing professionals on the West Coast, Sean Mansoory, Mardi Dier (Senior Advisor) and Gary Lyons (Senior Advisor), demonstrates HCR s commitment to its regional model and provides the firm with more scale and depth to better serve the needs of biopharmaceutical companies in that region.